Search

everythinglearnresearchcommunity

for

Search:↓

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Removing one ovary helped treat a woman's severe PCOS symptoms when medicine didn't work.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.